Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 133

1.

Molecular imaging of carotid artery atherosclerosis with PET: a systematic review.

Piri R, Gerke O, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 Nov 30. doi: 10.1007/s00259-019-04622-y. [Epub ahead of print] Review.

PMID:
31786626
2.

Adaptive trial designs in diagnostic accuracy research.

Zapf A, Stark M, Gerke O, Ehret C, Benda N, Bossuyt P, Deeks J, Reitsma J, Alonzo T, Friede T.

Stat Med. 2019 Nov 27. doi: 10.1002/sim.8430. [Epub ahead of print]

PMID:
31773788
3.

Atherosclerosis imaging with 18F-sodium fluoride PET: state-of-the-art review.

Høilund-Carlsen PF, Sturek M, Alavi A, Gerke O.

Eur J Nucl Med Mol Imaging. 2019 Nov 27. doi: 10.1007/s00259-019-04603-1. [Epub ahead of print] Review.

PMID:
31773235
4.

18F-sodium fluoride PET/CT provides prognostic clarity compared to calcium and Framingham risk scoring when addressing whole-heart arterial calcification.

Sorci O, Batzdorf AS, Mayer M, Rhodes S, Peng M, Jankelovits AR, Hornyak JN, Gerke O, Høilund-Carlsen PF, Alavi A, Rajapakse CS.

Eur J Nucl Med Mol Imaging. 2019 Nov 16. doi: 10.1007/s00259-019-04590-3. [Epub ahead of print]

PMID:
31734781
5.

18F-Fluoromethylcholine-positron emission tomography/computed tomography for diagnosing bone and lymph node metastases in patients with intermediate- or high-risk prostate cancer.

Mortensen MA, Poulsen MH, Gerke O, Jakobsen JS, Høilund-Carlsen PF, Lund L.

Prostate Int. 2019 Sep;7(3):119-123. doi: 10.1016/j.prnil.2019.01.002. Epub 2019 Jan 19.

6.

FDG-PET/CT Versus Contrast-Enhanced CT for Response Evaluation in Metastatic Breast Cancer: A Systematic Review.

Helland F, Hallin Henriksen M, Gerke O, Vogsen M, Høilund-Carlsen PF, Hildebrandt MG.

Diagnostics (Basel). 2019 Aug 27;9(3). pii: E106. doi: 10.3390/diagnostics9030106. Review.

7.

FDG-PET/CT for Response Monitoring in Metastatic Breast Cancer: Today, Tomorrow, and Beyond.

Hildebrandt MG, Lauridsen JF, Vogsen M, Holm J, Vilstrup MH, Braad PE, Gerke O, Thomassen M, Ewertz M, Høilund-Carlsen PF; Centre for Personalized Response Monitoring in Oncology (PREMIO).

Cancers (Basel). 2019 Aug 15;11(8). pii: E1190. doi: 10.3390/cancers11081190.

8.

Artificial intelligence-based versus manual assessment of prostate cancer in the prostate gland: a method comparison study.

Mortensen MA, Borrelli P, Poulsen MH, Gerke O, Enqvist O, Ulén J, Trägårdh E, Constantinescu C, Edenbrandt L, Lund L, Høilund-Carlsen PF.

Clin Physiol Funct Imaging. 2019 Nov;39(6):399-406. doi: 10.1111/cpf.12592. Epub 2019 Sep 8.

PMID:
31436365
9.

Hybrid PET/MRI in major cancers: a scoping review.

Morsing A, Hildebrandt MG, Vilstrup MH, Wallenius SE, Gerke O, Petersen H, Johansen A, Andersen TL, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2138-2151. doi: 10.1007/s00259-019-04402-8. Epub 2019 Jul 2.

PMID:
31267161
10.

Upfront PET/CT affects management decisions in patients with recurrent head and neck squamous cell carcinoma.

Rohde M, Nielsen AL, Johansen J, Sørensen JA, Diaz A, Pareek M, Asmussen JT, Gerke O, Thomassen A, Gyldenkerne N, Døssing H, Bjørndal K, Høilund-Carlsen PF, Godballe C.

Oral Oncol. 2019 Jul;94:1-7. doi: 10.1016/j.oraloncology.2019.04.025. Epub 2019 May 6.

PMID:
31178202
11.

Functional and Anatomical Testing in Intermediate Risk Chest Pain Patients with a High Coronary Calcium Score: Rationale and Design of the FACC Study.

Øvrehus KA, Veien KT, Lambrechtsen J, Rohold A, Steffensen FH, Gerke O, Jensen LO, Mickley H.

Cardiology. 2019;142(3):141-148. doi: 10.1159/000499667. Epub 2019 Jun 6.

PMID:
31170719
12.

Up-front F18-FDG PET/CT in suspected salivary gland carcinoma.

Westergaard-Nielsen M, Rohde M, Godballe C, Eriksen JG, Larsen SR, Gerke O, Nguyen N, Nielsen MK, Nielsen AL, Thomassen A, Asmussen JT, Diaz A, Høilund-Carlsen PF, Bjørndal K.

Ann Nucl Med. 2019 Aug;33(8):554-563. doi: 10.1007/s12149-019-01362-9. Epub 2019 May 17.

PMID:
31102059
13.

PET/CT-Based Response Evaluation in Cancer-a Systematic Review of Design Issues.

Gerke O, Ehlers K, Motschall E, Høilund-Carlsen PF, Vach W.

Mol Imaging Biol. 2019 Apr 23. doi: 10.1007/s11307-019-01351-4. [Epub ahead of print]

PMID:
31016638
14.

Long-Term Single-Center Retrospective Follow-Up After Embolization of Pulmonary Arteriovenous Malformations Treated Over a 20-year Period: Frequency of Re-canalization with Various Embolization Materials and Clinical Outcome.

Andersen PE, Duvnjak S, Gerke O, Kjeldsen AD.

Cardiovasc Intervent Radiol. 2019 Aug;42(8):1102-1109. doi: 10.1007/s00270-019-02204-x. Epub 2019 Mar 18.

PMID:
30887104
15.

Association between age, uptake of 18F-fluorodeoxyglucose and of 18F-sodium fluoride, as cardiovascular risk factors in the abdominal aorta.

Arani LS, Gharavi MH, Zadeh MZ, Raynor WY, Seraj SM, Constantinescu CM, Gerke O, Werner TJ, Høilund-Carlsen PF, Alavi A.

Hell J Nucl Med. 2019 Jan-Apr;22(1):14-19. doi: 10.1967/s002449910954. Epub 2019 Mar 7.

PMID:
30843005
16.

Evolving Role of PET in Detecting and Characterizing Atherosclerosis.

Høilund-Carlsen PF, Moghbel MC, Gerke O, Alavi A.

PET Clin. 2019 Apr;14(2):197-209. doi: 10.1016/j.cpet.2018.12.001. Review.

PMID:
30826018
17.

Osteoporosis and prostate cancer; a 24-month prospective observational study during androgen deprivation therapy.

Poulsen MH, Frost M, Abrahamsen B, Gerke O, Walter S, Lund L.

Scand J Urol. 2019 Feb;53(1):34-39. doi: 10.1080/21681805.2019.1570328. Epub 2019 Feb 19.

PMID:
30777478
18.

Diagnostic manifestations of total hemispheric glucose metabolism ratio in neuronal network diaschisis: diagnostic implications in Alzheimer's disease and mild cognitive impairment.

Segtnan EA, Majdi A, Constantinescu C, Grupe P, Gerke O, Dali HÍ, Strøm OE, Holm J, Alavi A, Sadigh-Eteghad S, Wermuth L, Hildebrandt MG, Gjedde A, Høilund-Carlsen PF.

Eur J Nucl Med Mol Imaging. 2019 May;46(5):1164-1174. doi: 10.1007/s00259-018-4248-0. Epub 2019 Jan 12.

PMID:
30637500
19.

A novel alignment procedure to assess calcified coronary plaques in histopathology, post-mortem computed tomography angiography and optical coherence tomography.

Precht H, Broersen A, Kitslaar PH, Dijkstra J, Gerke O, Thygesen J, Egstrup K, Leth PM, Hardt-Madsen M, Nielsen B, Falk E, Lambrechtsen J.

Cardiovasc Pathol. 2019 Mar - Apr;39:25-29. doi: 10.1016/j.carpath.2018.11.005. Epub 2018 Dec 7.

PMID:
30597423
20.

Clinical value of 18F-FDG-PET/CT in suspected serious disease with special emphasis on occult cancer.

Caspersen KB, Giannoutsou N, Gerke O, Alavi A, Høilund-Carlsen PF, Hess S.

Ann Nucl Med. 2019 Mar;33(3):184-192. doi: 10.1007/s12149-018-01322-9. Epub 2018 Dec 19.

PMID:
30569441

Supplemental Content

Loading ...
Support Center